MA29514B1 - Acides carboxylique (biphenyle) et leurs derives - Google Patents
Acides carboxylique (biphenyle) et leurs derivesInfo
- Publication number
- MA29514B1 MA29514B1 MA29911A MA29911A MA29514B1 MA 29514 B1 MA29514 B1 MA 29514B1 MA 29911 A MA29911 A MA 29911A MA 29911 A MA29911 A MA 29911A MA 29514 B1 MA29514 B1 MA 29514B1
- Authority
- MA
- Morocco
- Prior art keywords
- biphenyl
- derivatives
- carboxylic acids
- compounds
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D309/06—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
La présente invention concerne des composés ayant la formule générale (I) avec les définitions de A, X, R1-R6 données ci-après, et/ou un sel ou un ester de ces composés. L'invention concerne également l'utilisation de ces composés pour le traitement de la maladie d'Alzheimer et leur utilisation pour la modulation de l'activité de ?-secrétase.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04025003 | 2004-10-21 | ||
EP04026125A EP1650183A1 (fr) | 2004-10-21 | 2004-11-04 | L'acides acétiques (de benzyloxy-biphenyle) et de leurs derives ainsi que leurs utilisation en thérapie |
US64210005P | 2005-01-10 | 2005-01-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29514B1 true MA29514B1 (fr) | 2008-06-02 |
Family
ID=34927231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29911A MA29514B1 (fr) | 2004-10-21 | 2007-05-17 | Acides carboxylique (biphenyle) et leurs derives |
Country Status (29)
Country | Link |
---|---|
US (1) | US7825160B2 (fr) |
EP (2) | EP1650183A1 (fr) |
JP (1) | JP5054532B2 (fr) |
KR (1) | KR101326358B1 (fr) |
CN (1) | CN101084178B (fr) |
AP (1) | AP2007003978A0 (fr) |
AT (1) | ATE425952T1 (fr) |
AU (1) | AU2005298880B2 (fr) |
BR (1) | BRPI0517467A (fr) |
CA (1) | CA2584664C (fr) |
DE (1) | DE602005013417D1 (fr) |
DK (1) | DK1805129T3 (fr) |
EA (1) | EA012417B1 (fr) |
ES (1) | ES2324307T3 (fr) |
GE (1) | GEP20105082B (fr) |
HR (1) | HRP20090316T1 (fr) |
IL (1) | IL182712A (fr) |
MA (1) | MA29514B1 (fr) |
MX (1) | MX2007004763A (fr) |
NI (1) | NI200700107A (fr) |
NO (1) | NO20072153L (fr) |
NZ (1) | NZ554724A (fr) |
PL (1) | PL1805129T3 (fr) |
PT (1) | PT1805129E (fr) |
RS (1) | RS50818B (fr) |
SI (1) | SI1805129T1 (fr) |
SM (1) | SMP200700016B (fr) |
TN (1) | TNSN07148A1 (fr) |
WO (1) | WO2006045554A1 (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006126514A1 (fr) * | 2005-05-27 | 2006-11-30 | Shionogi & Co., Ltd. | Derive d'arylacetate ayant un squelette isoxazole |
AU2008248129B8 (en) | 2007-05-07 | 2013-05-30 | Merck Sharp & Dohme Corp. | Gamma secretase modulators |
CA2689930A1 (fr) | 2007-06-01 | 2008-12-18 | Schering Corporation | Modulateurs de secretase gamma |
US8426403B2 (en) | 2007-06-01 | 2013-04-23 | Zhaoning Zhu | Gamma secretase modulators |
EP2178857A1 (fr) * | 2007-06-29 | 2010-04-28 | Schering Corporation | Modulateurs de la gamma-sécrétase |
WO2009032277A1 (fr) | 2007-09-06 | 2009-03-12 | Schering Corporation | Modulateurs de la gamma sécrétase |
US7897643B2 (en) * | 2007-10-17 | 2011-03-01 | Janssen Pharmaceutica N.V. | Biphenyl carboxylic acids and derivatives thereof |
US20090306392A1 (en) * | 2007-10-19 | 2009-12-10 | Chih Yung Ho | Gsm intermediates |
CN101903335A (zh) * | 2007-10-19 | 2010-12-01 | 詹森药业有限公司 | 连接有胺的γ-分泌酶调节剂 |
MX2010004309A (es) | 2007-10-19 | 2010-05-03 | Janssen Pharmaceutica Nv | Moduladores de piperidinil y piperazinil de gamma-secretasa. |
EP2215043B1 (fr) * | 2007-10-19 | 2013-03-06 | Janssen Pharmaceutica, N.V. | Modulateurs liés au carbone de la -sécrétase |
CA2702835A1 (fr) * | 2007-10-19 | 2009-04-23 | Janssen Pharmaceutica N.V. | Modulateurs de la g-secretase lies a un amide |
JP2011503002A (ja) | 2007-11-05 | 2011-01-27 | シェーリング コーポレイション | γセクレターゼ調節剤 |
WO2009067493A2 (fr) * | 2007-11-19 | 2009-05-28 | Envivo Pharmaceuticals, Inc. | Benzènes 1,3,5-trisubstitués pour le traitement de la maladie d'alzheimer et d'autres troubles |
US8450343B2 (en) | 2007-12-06 | 2013-05-28 | Xianhai Huang | Gamma secretase modulators |
CN101945868A (zh) | 2007-12-11 | 2011-01-12 | 先灵公司 | γ分泌酶调节剂 |
US8217064B2 (en) * | 2007-12-20 | 2012-07-10 | Envivo Pharmaceuticals, Inc. | Tetrasubstituted benzenes |
EP2133322A1 (fr) * | 2008-06-11 | 2009-12-16 | CHIESI FARMACEUTICI S.p.A. | Procédé de préparation de dérivés d'acide 1-(2-halobiphényl-4-yl)-cyclopropanecardxylique |
JP5503663B2 (ja) | 2008-11-13 | 2014-05-28 | メルク・シャープ・アンド・ドーム・コーポレーション | ガンマセクレターゼモジュレータ |
CA2742472A1 (fr) | 2008-11-13 | 2010-05-20 | Schering Corporation | Modulateurs de gamma secretase |
CA2747750A1 (fr) | 2008-12-22 | 2010-07-01 | Theodros Asberom | Modulateurs de gamma secretase |
US8759337B2 (en) | 2008-12-22 | 2014-06-24 | Merck Sharp & Dohme Corp. | Gamma secretase modulators |
WO2010147969A2 (fr) | 2009-06-16 | 2010-12-23 | Schering Corporation | Modulateurs de gamma sécrétase |
US20120232108A1 (en) | 2009-06-16 | 2012-09-13 | Xianhai Huang | Gamma secretase modulators |
US20120245158A1 (en) | 2009-06-16 | 2012-09-27 | Xianhai Huang | Gamma secretase modulators |
US20120129189A1 (en) * | 2009-07-17 | 2012-05-24 | Chulan Kwon | Methods of Controlling Cell Proliferation |
ES2437163T3 (es) * | 2009-08-04 | 2014-01-09 | Chiesi Farmaceutici S.P.A. | Procesos para la preparación de derivados del ácido 1-(2-halobifenil-4-il)-ciclopropanocarboxílico |
CA2850881C (fr) | 2012-04-20 | 2021-02-16 | Gilead Sciences, Inc. | Derives d'acide benzothiazol-6-yl acetique et leur utilisation dans le traitement d'une infection par le vih |
CN104045552B (zh) * | 2013-03-13 | 2019-06-11 | 江苏先声药业有限公司 | 作为神经保护剂的药用化合物 |
WO2016201168A1 (fr) | 2015-06-10 | 2016-12-15 | Forum Pharmceuticals Inc. | Composés oxadiazine et leurs méthodes d'utilisation |
EP3840834A2 (fr) * | 2018-08-24 | 2021-06-30 | Xeniopro GmbH | Nouveaux composés |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1284729A4 (fr) * | 2000-04-13 | 2007-12-19 | Mayo Foundation | Agents de reduction de a(beta)42 |
EP1435946B8 (fr) * | 2001-09-14 | 2013-12-18 | Amgen Inc. | Composes biaryles lies |
CA2512704A1 (fr) * | 2003-01-14 | 2004-08-05 | Merck & Co., Inc. | Derives de nsaid a disubstitution geminale servant d'agents reducteurs de abeta 42 |
ITMI20030312A1 (it) * | 2003-02-21 | 2004-08-22 | Chiesi Farma Spa | Derivati di acidi 2-fenil-2-alchil-acetici per il trattamento della malattia di alzheimer. |
GB0416508D0 (en) * | 2004-07-23 | 2004-08-25 | Merck Sharp & Dohme | Therapeutic agents |
EP1657232A1 (fr) * | 2004-11-05 | 2006-05-17 | Cellzome Ag | utilisation d'acides 2-arylacetiques alphasubstitues pour prevenir la maladie d'alzheimer |
-
2004
- 2004-11-04 EP EP04026125A patent/EP1650183A1/fr not_active Withdrawn
-
2005
- 2005-10-21 NZ NZ554724A patent/NZ554724A/en not_active IP Right Cessation
- 2005-10-21 CN CN2005800436804A patent/CN101084178B/zh not_active Expired - Fee Related
- 2005-10-21 PL PL05799330T patent/PL1805129T3/pl unknown
- 2005-10-21 GE GEAP200510076A patent/GEP20105082B/en unknown
- 2005-10-21 SM SM200700016T patent/SMP200700016B/it unknown
- 2005-10-21 EP EP05799330A patent/EP1805129B1/fr active Active
- 2005-10-21 US US11/665,760 patent/US7825160B2/en not_active Expired - Fee Related
- 2005-10-21 DK DK05799330T patent/DK1805129T3/da active
- 2005-10-21 BR BRPI0517467-8A patent/BRPI0517467A/pt not_active IP Right Cessation
- 2005-10-21 ES ES05799330T patent/ES2324307T3/es active Active
- 2005-10-21 PT PT05799330T patent/PT1805129E/pt unknown
- 2005-10-21 AP AP2007003978A patent/AP2007003978A0/xx unknown
- 2005-10-21 AU AU2005298880A patent/AU2005298880B2/en not_active Ceased
- 2005-10-21 SI SI200530663T patent/SI1805129T1/sl unknown
- 2005-10-21 AT AT05799330T patent/ATE425952T1/de active
- 2005-10-21 WO PCT/EP2005/011349 patent/WO2006045554A1/fr active Application Filing
- 2005-10-21 EA EA200700860A patent/EA012417B1/ru not_active IP Right Cessation
- 2005-10-21 JP JP2007537225A patent/JP5054532B2/ja not_active Expired - Fee Related
- 2005-10-21 KR KR1020077009097A patent/KR101326358B1/ko not_active IP Right Cessation
- 2005-10-21 DE DE602005013417T patent/DE602005013417D1/de active Active
- 2005-10-21 CA CA2584664A patent/CA2584664C/fr not_active Expired - Fee Related
- 2005-10-21 MX MX2007004763A patent/MX2007004763A/es active IP Right Grant
- 2005-10-21 RS RSP-2009/0243A patent/RS50818B/sr unknown
-
2007
- 2007-04-19 TN TNP2007000148A patent/TNSN07148A1/fr unknown
- 2007-04-20 NI NI200700107A patent/NI200700107A/es unknown
- 2007-04-22 IL IL182712A patent/IL182712A/en not_active IP Right Cessation
- 2007-04-25 NO NO20072153A patent/NO20072153L/no not_active Application Discontinuation
- 2007-05-17 MA MA29911A patent/MA29514B1/fr unknown
-
2009
- 2009-05-29 HR HR20090316T patent/HRP20090316T1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA29514B1 (fr) | Acides carboxylique (biphenyle) et leurs derives | |
MA30475B1 (fr) | Acides biphenyl carboxyliques substitutes et derives en resultant. | |
MA42295B1 (fr) | Composés de la benzoxazépin oxazolidinone et procédé pour leur utilisation | |
MA30402B1 (fr) | Acides carboxyliques substitues par des phenylamino-benzoxazoles, leur procede de production et leur utilisation comme medicaments | |
ATE343388T1 (de) | Pde-v hemmer zur behandlung von morbus parkinson | |
MA33509B1 (fr) | Dérivés de l'oxazine et leur utilisation dans le traitement de troubles neurologiques | |
MA27472A1 (fr) | Acetyle 2-hydroxy-1, 3 diaminoalcanes | |
MA27769A1 (fr) | Dérivées de 2-acylamino-4-phenylthiazole, leur préparation et leur application en thérapeutique | |
MA32351B1 (fr) | Derives d'aminodihydrothiazine a titre d'inhibiteurs de bace pour le traitement de la maladie d'alzheimer | |
ATE318267T1 (de) | Einige alkylendiamin-substituierte heterocyclen | |
DE602004022633D1 (de) | 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen | |
EA200900152A1 (ru) | Ингибиторы пирролотриазинкиназы | |
MA34361B1 (fr) | Dérivés de tétrahydro-pyrido-pyrimidine | |
EA200802054A1 (ru) | Ингибиторы фермента | |
EA200300716A1 (ru) | Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6 | |
MA29464B1 (fr) | Methode de preparation d'acides 1,6-dihydro-6-oxo-4-pyrimidinecarboxyliques eventuellement 2-substitues | |
ATE517861T1 (de) | Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
MA27692A1 (fr) | Composes derives de benzoxazinone, leur preparation et utilisation comme medicaments | |
ATE389395T1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
MA30420B1 (fr) | Derives de terphenyle pour le traitment de la maladie d'alzheimer | |
MA28562B1 (fr) | 1,3,4-oxadiazol-2-ones comme modulateurs de ppar delta et leur utilisation | |
ATE380816T1 (de) | Substituierte imidazopyrimidine zur prävention und behandlung von krebs | |
MA29593B1 (fr) | Derives de benzooxazol-2- one en tant qu'inhibiteurs de lipase et de phospholipase | |
MA33917B1 (fr) | Dérivés d'acide carboxylique ayant un cycle oxazolopyrimidine 2,5-substitue | |
TW200800966A (en) | Beta-secretase modulators and methods of use |